{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:58:12Z","timestamp":1792205892798,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.tmaid.2023.102549","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T06:37:51Z","timestamp":1676615871000},"page":"102549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Artemether-lumefantrine, mefloquine and atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria in travellers: A retrospective comparative study of efficacy and treatment failures"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7100-0310","authenticated-orcid":false,"given":"Vyacheslav","family":"Grebenyuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franti\u0161ek","family":"Stejskal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Noh\u00fdnkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Zicklerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Richterov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Roh\u00e1\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanu\u0161","family":"Rozsypal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Troj\u00e1nek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2023.102549_bib1","series-title":"ECDC. Annual epidemiological report for 2019","article-title":"Malaria","year":"2021"},{"issue":"1","key":"10.1016\/j.tmaid.2023.102549_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12936-017-1936-3","article-title":"Malaria after international travel: a GeoSentinel analysis, 2003-2016","volume":"16","author":"Angelo","year":"2017","journal-title":"Malar J"},{"issue":"4","key":"10.1016\/j.tmaid.2023.102549_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/cc2183","article-title":"Clinical review: severe malaria","volume":"7","author":"Trampuz","year":"2003","journal-title":"Crit Care"},{"key":"10.1016\/j.tmaid.2023.102549_bib4","series-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2015"},{"issue":"1","key":"10.1016\/j.tmaid.2023.102549_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar J"},{"issue":"6","key":"10.1016\/j.tmaid.2023.102549_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(15)70024-1","article-title":"The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data","volume":"15","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.tmaid.2023.102549_bib7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1473-3099(16)30020-2","article-title":"Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial","volume":"16","author":"Sirima","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2023.102549_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12936-020-03287-5","volume":"19","author":"Mhamilawa","year":"2020","journal-title":"Malar J"},{"issue":"2","key":"10.1016\/j.tmaid.2023.102549_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/cid\/ciw710","article-title":"High rate of treatment failures in nonimmune travelers treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Sweden: retrospective comparative analysis of effectiveness and case series","volume":"64","author":"Sond\u00e9n","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2023.102549_bib10","series-title":"Malaria microscopy standard operating procedure - MM-SOP-09","year":"2016"},{"issue":"10","key":"10.1016\/j.tmaid.2023.102549_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003359","article-title":"The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: a systematic review and a pooled multicentre individual-patient meta-analysis","volume":"17","author":"Mousa","year":"2020","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.tmaid.2023.102549_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12936-016-1408-1","article-title":"Impact of using artemisinin-based combination therapy (ACT) in the treatment of uncomplicated malaria from Plasmodium falciparum in a non-endemic zone","volume":"15","author":"Pousibet-Puerto","year":"2016","journal-title":"Malar J"},{"issue":"6","key":"10.1016\/j.tmaid.2023.102549_bib14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/0035-9203(95)90435-2","article-title":"Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria","volume":"89","author":"ter Kuile","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.tmaid.2023.102549_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/322694","article-title":"Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study","volume":"33","author":"Overbosch","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2023.102549_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/dkx431","article-title":"Clinical implications of Plasmodium resistance to atovaquone\/proguanil: a systematic review and meta-analysis","volume":"73","author":"Staines","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.tmaid.2023.102549_bib17","first-page":"CD007483","article-title":"Artemisinin-based combination therapy for treating uncomplicated malaria","volume":"2009","author":"Sinclair","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.tmaid.2023.102549_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.7883\/yoken.JJID.2009.139","article-title":"First case of treatment failure of artemether-lumefantrine in a Japanese traveler with imported falciparum malaria","volume":"62","author":"Mizuno","year":"2009","journal-title":"Jpn J Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2023.102549_bib19","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2011.041","article-title":"Possible clinical failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria","volume":"3","author":"Repetto","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2023.102549_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4269\/ajtmh.2008.78.241","article-title":"Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study","volume":"78","author":"Hatz","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2023.102549_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12936-015-0956-0","article-title":"Is there malaria transmission in urban settings in Colombia?","volume":"14","author":"Padilla","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.tmaid.2023.102549_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1475-2875-11-212","article-title":"Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study","volume":"11","author":"Bouchaud","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.tmaid.2023.102549_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12936-015-0881-2","article-title":"Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysis","volume":"14","author":"Gray","year":"2015","journal-title":"Malar J"},{"issue":"10","key":"10.1016\/j.tmaid.2023.102549_bib24","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1128\/AAC.00481-15","article-title":"How robust are malaria parasite clearance rates as indicators of drug effectiveness and resistance?","volume":"59","author":"Hastings","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.tmaid.2023.102549_bib25","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/S2214-109X(16)30236-4","volume":"5","author":"Mavoko","year":"2017","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.tmaid.2023.102549_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz082","article-title":"Plasmodium falciparum malaria recrudescence after treatment with artemether-lumefantrine","volume":"27","author":"Bourque","year":"2020","journal-title":"J Trav Med"},{"issue":"2","key":"10.1016\/j.tmaid.2023.102549_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine","volume":"37","author":"White","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.tmaid.2023.102549_bib28","first-page":"ciac783","article-title":"The impact of extended treatment with artemether-lumefantrine on antimalarial exposure and reinfection risks in Ugandan children with uncomplicated malaria: a randomized controlled trial","author":"Whalen","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2023.102549_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12936-018-2404-4","article-title":"Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar","volume":"17","author":"Tun","year":"2018","journal-title":"Malar J"},{"issue":"10","key":"10.1016\/j.tmaid.2023.102549_bib30","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/cid\/cix262","article-title":"Artemether-lumefantrine treatment failure in nonimmune European travelers with Plasmodium falciparum malaria: do we need to reconsider dosing in patients from nonendemic regions?","volume":"64","author":"Neumayr","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.tmaid.2023.102549_bib31","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3201\/eid2707.203230","article-title":"Plasmodium falciparum kelch 13 mutations, 9 countries in Africa, 2014-2018","volume":"27","author":"Schmedes","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2023.102549_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02382-16","article-title":"pfk13-Independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemether-lumefantrine in the United Kingdom","volume":"61","author":"Sutherland","year":"2017","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893923000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893923000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:10:03Z","timestamp":1761487803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893923000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":31,"alternative-id":["S1477893923000091"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2023.102549","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artemether-lumefantrine, mefloquine and atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria in travellers: A retrospective comparative study of efficacy and treatment failures","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2023.102549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102549"}}